Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study

References

• Croia C, Bursi R, Sutera D, Petrelli F, Alunno A, Puxeddu I. One year in review 2019: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 2019;37:347–57.
   PubMed Web of Science ®Google Scholar
• Chen L, Huang Z, Yang B, Cai B, Su Z, Wang L. Association of E26 transformation specific sequence 1 variants with rheumatoid arthritis in Chinese Han population. PLoS One 2015;10:e0134875.
   PubMed Web of Science ®Google Scholar
• Myasoedova E, Davis J, Matteson EL, Crowson CS. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014. Ann Rheum Dis 2020;79:440–4.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE, et al. Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study. Clin Exp Rheumatol 2021;39:995–1002.
   PubMed Web of Science ®Google Scholar
• Su CC, Chen Ie C, Young FN, Lian Ie B. Risk of diabetes in patients with rheumatoid arthritis: a 12-year retrospective cohort study. J Rheumatol 2013;40:1513–18.
   PubMed Web of Science ®Google Scholar
• Baghdadi LR. Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: a systematic review and meta-analysis. PLoS One 2020;15:e0235637.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang Y, Zhang SY. Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future. Chin Med J (Engl) 2019;132:2972–83.
   PubMed Web of Science ®Google Scholar
• Tinggaard AB, de Thurah A, Andersen IT, Riis AH, Therkildsen J, Winther S, et al. Rheumatoid arthritis as a risk factor for coronary artery calcification and obstructive coronary artery disease in patients with chest pain: a registry based cross-sectional study. Clin Epidemiol 2020;12:679–89.
   PubMed Web of Science ®Google Scholar
• Semb AG, Kvien TK, Aastveit AH, Jungner I, Pedersen TR, Walldius G, et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) study. Ann Rheum Dis 2010;69:1996–2001.
   PubMed Web of Science ®Google Scholar
• Meune C, Touzé E, Trinquart L, Allanore Y. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 2010;103:253–61.
   PubMed Web of Science ®Google Scholar
• Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008;59:1090–6.
   PubMed Web of Science ®Google Scholar
• Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1–22.
   PubMed Web of Science ®Google Scholar
• Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA 2017;318:1925–6.
   PubMed Web of Science ®Google Scholar
• Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014;506:376–81.
   PubMed Web of Science ®Google Scholar
• Grover S, Del Greco MF, Stein CM, Ziegler A. Mendelian randomization. Methods Mol Biol 2017;1666:581–628.
   PubMedGoogle Scholar
• Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet 2018;50:1505–13.
   PubMed Web of Science ®Google Scholar
• Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015;47:1121–30.
   PubMed Web of Science ®Google Scholar
• Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet 2018;50:524–37.
   PubMed Web of Science ®Google Scholar
• Burgess S, Thompson SG. Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med 2011;30:1312–23.
   PubMed Web of Science ®Google Scholar
• Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013;37:658–65.
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016;40:304–14.
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhuang H, Yang S, Jiang H, Wang S, Zhang J. Exposing the causal effect of C-reactive protein on the risk of type 2 diabetes mellitus: a mendelian randomization study. Front Genet 2018;9:657.
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015;44:512–25.
   PubMed Web of Science ®Google Scholar
• Wu F, Huang Y, Hu J, Shao Z. Mendelian randomization study of inflammatory bowel disease and bone mineral density. BMC Med 2020;18:312.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Ursini F, Cipriani P, Ciccia F, Liakouli V, Carubbi F, et al. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: results from a cross-sectional study. Medicine (Baltimore) 2017;96:e7896.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Ursini F, Cipriani P, Liakouli V, Carubbi F, Berardicurti O, et al. Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: a 1-year, single-centre, longitudinal study. PLoS One 2017;12:e0181203.
   PubMed Web of Science ®Google Scholar
• Avouac J, Elhai M, Forien M, Sellam J, Eymard F, Molto A, et al. Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetes. Rheumatology (Oxford) 2021;60:3598–606.
   PubMed Web of Science ®Google Scholar
• Chen YR, Hsieh FI, Chang CC, Chi NF, Wu HC, Chiou HY. The effect of rheumatoid arthritis on the risk of cerebrovascular disease and coronary artery disease in young adults. J Chin Med Assoc 2018;81:772–80.
   PubMed Web of Science ®Google Scholar
• de Thurah A, Andersen IT, Tinggaard AB, Riis AH, Therkildsen J, Bøtker HE, et al. Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment. RMD Open 2020;6:e001113.
   PubMed Web of Science ®Google Scholar
• Hansen PR, Feineis M, Abdulla J. Rheumatoid arthritis patients have higher prevalence and burden of asymptomatic coronary artery disease assessed by coronary computed tomography: a systematic literature review and meta-analysis. Eur J Intern Med 2019;62:72–9.
   PubMed Web of Science ®Google Scholar
• Södergren A, Stegmayr B, Ohman ML, Wållberg-Jonsson S. Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis. Clin Exp Rheumatol 2009;27:641–4.
   PubMed Web of Science ®Google Scholar
• Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004;63:952–5.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205–19.
   PubMed Web of Science ®Google Scholar
• Patel R, Palit SP, Rathwa N, Ramachandran AV, Begum R. Genetic variants of tumor necrosis factor-α and its levels: a correlation with dyslipidemia and type 2 diabetes susceptibility. Clin Nutr 2019;38:1414–22.
   PubMed Web of Science ®Google Scholar
• Antonioli L, Moriconi D, Masi S, Bottazzo D, Pellegrini C, Fornai M, et al. Differential impact of weight loss and glycemic control on inflammasome signaling. Obesity (Silver Spring) 2020;28:609–15.
   PubMed Web of Science ®Google Scholar
• Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11:98–107.
   PubMed Web of Science ®Google Scholar
• Giacomelli R, Ruscitti P, Alvaro S, Ciccia F, Liakouli V, Di Benedetto P, et al. IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? Expert Rev Clin Immunol 2016;12:849–55.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Ursini F, Cipriani P, Greco M, Alvaro S, Vasiliki L, et al. IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: an observational study. Medicine (Baltimore) 2019;98:e14587.
   PubMed Web of Science ®Google Scholar
• Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis 2014;73:1797–804.
   PubMed Web of Science ®Google Scholar
• Braun J, März W, Winkelmann BR, Donner H, Henning Usadel K, Badenhoop K. Tumour necrosis factor beta alleles and hyperinsulinaemia in coronary artery disease. Eur J Clin Invest 1998;28:538–42.
   PubMed Web of Science ®Google Scholar
• Yang HT, Wang SL, Yan LJ, Qian P, Duan HY. Association of interleukin gene polymorphisms with the risk of coronary artery disease. Genet Mol Res 2015;14:12489–96.
   PubMed Web of Science ®Google Scholar
• Mohammad-Rezaei M, Ahmadi R, Rafiei A, Khaledifar A, Fattahi S, Samiei-Sefat A, et al. Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-α. Mol Biol Rep 2021;48:4263–71.
   PubMed Web of Science ®Google Scholar
• Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, et al. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation 2004;109:1966–72.
   PubMed Web of Science ®Google Scholar
• Marigorta UM, Navarro A. High trans-ethnic replicability of GWAS results implies common causal variants. PLoS Genet 2013;9:e1003566.
   PubMed Web of Science ®Google Scholar